Life-years gained among US adults from modern treatments and changes in the prevalence of 6 coronary heart disease risk factors between 1980 and 2000.

Has the recent US decline in coronary heart disease (CHD) mortality increased life expectancy? The authors estimated the number of life-years gained from CHD treatments and changes in the prevalence of cardiovascular disease risk factors for the US population between 1980 and 2000. The previously validated IMPACT model was used to integrate data on numbers of CHD patients, treatment uptake, treatment effectiveness, population risk factor trends, and median survival among US adults. There were 308,900 fewer CHD deaths in 2000 among Americans aged 25-84 years than if 1980 mortality rates had applied. These 308,900 fewer deaths represented approximately 3,147,800 life-years gained (sensitivity analysis range, 2,448,900-3,744,900). Treatments for patients accounted for approximately 1,092,400 (751,700-1,387,000) life-years gained, whereas changes in the prevalence of population risk factors accounted for a gain of 2,055,500 (1,697,200-2,346,300) life-years. However, the 2,770,500 life-years gained through decreased levels of smoking, cholesterol, blood pressure, and physical inactivity were diminished by a loss of 715,000 life-years attributable to increased rates of obesity and diabetes. Therefore, modest reductions in the prevalence of several major cardiovascular disease risk factors accounted for more than twice as many life-years gained as did treatments. Unfortunately, these gains were partially offset by substantial increases in obesity and diabetes.

[1]  Oscar H Franco,et al.  Effects of physical activity on life expectancy with cardiovascular disease. , 2005, Archives of internal medicine.

[2]  E. Arias,et al.  United States life tables, 2005. , 2010, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[3]  L. Goldman,et al.  The recent decline in mortality from coronary heart disease, 1980-1990. The effect of secular trends in risk factors and treatment. , 1997, JAMA.

[4]  F. McAlister,et al.  Commentary: relative treatment effects are consistent across the spectrum of underlying risks...usually. , 2002, International journal of epidemiology.

[5]  S. Olshansky,et al.  A potential decline in life expectancy in the United States in the 21st century. , 2005, The New England journal of medicine.

[6]  Walter Willett,et al.  Changes in dietary fat and declining coronary heart disease in Poland: population based study , 2005, BMJ : British Medical Journal.

[7]  J. Critchley,et al.  LIFE-YEARS GAINED FROM MODERN CARDIOLOGICAL TREATMENTS AND POPULATION RISK FACTOR CHANGES IN ENGLAND AND WALES, 1981–2000 , 2005 .

[8]  J P Bunker,et al.  The role of medical care in contributing to health improvements within societies. , 2001, International journal of epidemiology.

[9]  B. J. Gersh.  Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000 , 2008 .

[10]  Judy Kruger,et al.  Prevalence of regular physical activity among adults--United States, 2001 and 2005. , 2007, MMWR. Morbidity and mortality weekly report.

[11]  A. Dyer,et al.  Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women. , 1999, JAMA.

[12]  L. Coupal,et al.  Estimating the benefits of modifying risk factors of cardiovascular disease: a comparison of primary vs secondary prevention. , 1998, Archives of internal medicine.

[13]  P. Armstrong,et al.  Impact of sex on long-term mortality from acute myocardial infarction vs unstable angina. , 2003, Archives of internal medicine.

[14]  J. McMurray,et al.  Short-term and long-term outcomes in 133 429 emergency patients admitted with angina or myocardial infarction in Scotland, 1990–2000: population-based cohort study , 2006, Heart.

[15]  M. Gail,et al.  Cause-specific excess deaths associated with underweight, overweight, and obesity. , 2007, JAMA.

[16]  F. Hu,et al.  Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300 000 persons. , 2007, Archives of internal medicine.

[17]  Ari B. Friedman,et al.  The Reversal of Fortunes: Trends in County Mortality and Cross-County Mortality Disparities in the United States , 2008, PLoS medicine.

[18]  K. Bennett,et al.  EVIDENCE BASED PUBLIC HEALTH POLICY AND PRACTICE Explaining the recent decrease in coronary heart disease mortality rates in Ireland, 1985–2000 , 2006 .

[19]  P. Adab,et al.  Age-specific relevance of usual blood pressure to vascular mortality , 2003, The Lancet.

[20]  J. Yudkin.  How can we best prolong life? Benefits of coronary risk factor reduction in non-diabetic and diabetic subjects. , 1993, BMJ.

[21]  J. Critchley,et al.  Modelling the decline in coronary heart disease deaths in England and Wales, 1981-2000: comparing contributions from primary prevention and secondary prevention , 2005, BMJ : British Medical Journal.

[22]  JohnMcMurray,et al.  Explanation for the Decline in Coronary Heart Disease Mortality Rates in Auckland, New Zealand, Between 1982 and 1993 , 2000 .

[23]  J. Pell,et al.  Evidence of Improving Prognosis in Heart Failure: Trends in Case Fatality in 66 547 Patients Hospitalized Between 1986 and 1995 , 2000, Circulation.

[24]  N J Wald,et al.  By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? , 1994, BMJ.

[25]  J. Critchley,et al.  Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. , 2003, JAMA.

[26]  V. Salomaa,et al.  Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. , 2005, American journal of epidemiology.

[27]  K. Bennett,et al.  Life-years-gained from population risk factor changes and modern cardiology treatments in Ireland. , 2007, European journal of public health.

[28]  A Briggs,et al.  Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. , 1994, Health economics.

[29]  Simon Capewell,et al.  Explaining the Decline in Coronary Heart Disease Mortality in England and Wales Between 1981 and 2000 , 2004, Circulation.

[30]  Steven Hawken,et al.  Preventive cardiologyAbstractsEffect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study , 2004 .

[31]  L. Goldman,et al.  Expected Gains in Life Expectancy From Various Coronary Heart Disease Risk Factor Modifications , 1991, Circulation.

[32]  J. McMurray,et al.  Explanation for the Decline in Coronary Heart Disease Mortality Rates in Auckland, New Zealand, Between 1982 and 1993 , 2000, Circulation.

[33]  D. Pryor,et al.  Estimated contribution of coronary artery bypass graft surgery to the decline in coronary heart disease mortality: the Minnesota Heart Survey. , 1994, Journal of the American College of Cardiology.